MBRX · Company research
Moleculin Biotech, Inc. (MBRX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Moleculin Biotech, Inc. (MBRX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Moleculin Biotech, Inc. (MBRX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| 415,000 options and an equal stock grant go to Moleculin Biotech (MBRX) CEO Walter V. Klemp. - Stock Titan | 415,000 options and an equal stock grant go to Moleculin Biotech (MBRX) CEO Walter V. Klemp. Stock Titan | View source ↗ | Stock Titan | Oct 17, 2026 | neutral | 0 | 0.6 |
| Half of a 250,000-option grant vests on the grant date at Moleculin Biotech (MBRX). - Stock Titan | Half of a 250,000-option grant vests on the grant date at Moleculin Biotech (MBRX). Stock Titan | View source ↗ | Stock Titan | Oct 17, 2026 | neutral | 0 | 0.6 |
| Half of the CFO's stock awards vest on grant at Moleculin Biotech (MBRX). - Stock Titan | Half of the CFO's stock awards vest on grant at Moleculin Biotech (MBRX). Stock Titan | View source ↗ | Stock Titan | Oct 17, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 16, 2026 | neutral | 0 | 0.6 |
| Moleculin Biotech (MBRX) Slides 6.33% to $0.39 as Micro-Cap Pressure Builds - Fibonacci Time Zone - https://www.siam.in/ | Moleculin Biotech (MBRX) Slides 6.33% to $0.39 as Micro-Cap Pressure Builds - Fibonacci Time Zone https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 15, 2026 | neutral | 0 | 0.6 |
| LUNR, FLY Stock Gains on Winning NASA Lunar Contracts In Moon Base Project - Stocktwits | LUNR, FLY Stock Gains on Winning NASA Lunar Contracts In Moon Base Project Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance - Stocktwits | MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Moleculin Biotech Inc (MBRX) Stock Price Target & Forecast - TradingKey | Moleculin Biotech Inc (MBRX) Stock Price Target & Forecast TradingKey | View source ↗ | TradingKey | Oct 8, 2026 | neutral | 0 | 0.6 |
| A leukemia trial finished enrolling 89 people. Full results are expected in early 2027. - Stock Titan | A leukemia trial finished enrolling 89 people. Full results are expected in early 2027. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| MBRX Should I Buy - Intellectia AI | MBRX Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Sep 26, 2026 | neutral | 0 | 0.6 |
| A cancer drug may help immune cells attack pancreatic tumors, early tests suggest. - Stock Titan | A cancer drug may help immune cells attack pancreatic tumors, early tests suggest. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Moleculin Biotech (MBRX) Upgraded to Buy: Here's Why - Yahoo Finance | Moleculin Biotech (MBRX) Upgraded to Buy: Here's Why Yahoo Finance | View source ↗ | Yahoo Finance | Aug 24, 2026 | neutral | 0 | 0.6 |
| Should I buy Moleculin Biotech (MBRX) - Zacks Investment Research | Should I buy Moleculin Biotech (MBRX) Zacks Investment Research | View source ↗ | Zacks Investment Research | Aug 24, 2026 | neutral | 0 | 0.6 |
| MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance - Yahoo Finance | MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| Why is Moleculin Stock Falling Today? - Benzinga | Why is Moleculin Stock Falling Today? Benzinga | View source ↗ | Benzinga | Jun 30, 2026 | neutral | 0 | 0.6 |
| MBRX Forecast — Price Target — Prediction for 2027 - TradingView | MBRX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 27, 2026 | neutral | 0 | 0.6 |
| MBRX Stock Draws Trader Focus As Volatility Spikes - www.timothysykes.com | MBRX Stock Draws Trader Focus As Volatility Spikes www.timothysykes.com | View source ↗ | www.timothysykes.com | Jun 23, 2026 | neutral | 0 | 0.6 |
| MBRX Stock Whipsaws As Traders Focus On Cash Runway - StocksToTrade | MBRX Stock Whipsaws As Traders Focus On Cash Runway StocksToTrade | View source ↗ | StocksToTrade | Jun 23, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.